Aillis
An AI-powered medical device for early and accurate influenza detection.
Launch date
Employees
Market cap
-
Enterprise valuation
€41—62m (Dealroom.co estimates May 2019.)
Tokyo Japan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Series B | ||
* | N/A | - | |
$8.7m | Late VC | ||
* | $1.0m | Grant | |
* | N/A | Series D | |
| Total Funding | €19.1m | ||
Related Content
Recent News about Aillis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.